Clinical Trial: A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R for Patients With Richter's Syndrome

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional



Official Title: Venetoclax Plus Dose-adjusted EPOCH-R for Richter's Syndrome

Brief Summary:

This research study is evaluating the combination of a study drug, venetoclax, and a standard chemotherapy regimen, EPOCH-R, as a possible treatment for Richter's Syndrome.

The drugs involved in this study are:

  • Venetoclax
  • EPOCH-R:
  • Etoposide
  • Prednisone
  • Vincristine Sulfate (Oncovin)
  • Cyclophosphamide
  • Doxorubicin Hydrochloride (Hydroxydaunomycin)
  • Rituximab